GuidelineParasitology2021
Guidelines for the diagnosis and treatment of neuroangiostrongyliasis: updated recommendations.
Guideline in Parasitology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed.
- Human Neuroangiostrongyliasis Caused by Angiostrongylus cantonensis in Northern Vietnam: a Clinical-Epidemiological Case Series of Eosinophilic Response and Disease Manifestations.Acta parasitologica · 2026Article
- Clinical recovery of severe infantileWorld journal of clinical pediatrics · 2026Article
- Cluster of 19 cases of eosinophilic meningitis due to Angiostrongylus cantonensis in Lifou, New Caledonia: an outbreak investigation.Infectious diseases of poverty · 2026Article
- Assessment of the Prevalence of Angiostrongylus cantonensis Infection in Gastropods of Puerto Rico.The American journal of tropical medicine and hygiene · 2026Article
- Probing Cinnamamides and Benzamides as Anthelmintics: Discovery of Potent Drug-Like Agents Against Angiostrongylus cantonensis.Chemical biology & drug design · 2026Article
- Immunodominant IgM Epitopes of theInternational journal of molecular sciences · 2026Article
- Climate-driven invasion ofOne health (Amsterdam, Netherlands) · 2026Article
- An Outbreak of Neuroangiostrongyliasis (Rat Lungworm Disease) in Hawai'i: Evidence Supporting the Early Use of Albendazole-Corticosteroid Co-Therapy.The American journal of tropical medicine and hygiene · 2026Article
- Albendazole-doxycycline combination therapy alleviates MRI- and pathology-evident neuroinflammation and restores IL-33/GFAP balance in mouse neuroangiostrongyliasis.Parasites & vectors · 2026Article
- Case Report: Neurological and pulmonary angiostrongylosis in a Ryukyu long-furred rat (Frontiers in parasitology · 2026Article
- Article
- Central nervous system infection by Angiostrongylus cantonensis in children: experience from Guangdong, China.BMC infectious diseases · 2025Article
- Antimicrobial Resistance and the Blood-Brain Barrier: Complex Interactions and Implications for Neurological Health.Molecular neurobiology · 2025Review
- Detection of Rat Lungworm (Angiostrongylus cantonensis) in Rats and Gastropods, Italy.Emerging infectious diseases · 2025Article
- Zoonotic Rat Lungworm Angiostrongylus cantonensis in Black Rats, Houston, Texas, 2024.Emerging infectious diseases · 2025Article
- Insights into the biology of the rat lungworm, Angiostrongylus cantonensis.Parasites & vectors · 2025Review
- Angiostrongylus cantonensis Meningo-Encephalitis in Children-Heightened Awareness Needed During Prolonged Wet Weather Conditions.Journal of paediatrics and child health · 2025Observational
- Living in the city: Angiostrongylus cantonensis is a novel threat to an urban population of Florida burrowing owls (Athene cunicularia floridana) in south Florida.Parasites & vectors · 2025Article
- Angiostrongylus cantonensis Meningoencephalitis in Three Pediatric Patients in Florida, USA.Journal of the Pediatric Infectious Diseases Society · 2024Article
- Detection of rat lungworm (Angiostrongylus cantonensis) infection by real-time PCR from the peripheral blood of animals: a preliminary study.Parasitology research · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A subcommittee of the Hawaii Governor's Joint Task Force on Rat Lungworm Disease developed preliminary guidelines for the diagnosis and treatment of neuroangiostrongyliasis (NAS) in 2018 (Guidelines, 2018). This paper reviews the main points of those guidelines and provides updates in areas where our understanding of the disease has increased. The diagnosis of NAS is described, including confirmation of infection by real-time polymerase chain reaction (RTi-PCR) to detect parasite DNA in the central nervous system (CNS). The treatment literature is reviewed with recommendations for the use of corticosteroids and the anthelminthic drug albendazole. Long-term sequelae of NAS are discussed and recommendations for future research are proposed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.